growth disorders
Showing 1 - 25 of 59
PEGylated GH for Treatment of Short Stature in Chinese
Recruiting
- Growth Hormone Treatment
- Growth Disorders
- Polyethylene glycol recombinant human growth hormone injection
-
Beijing, Beijing, ChinaDepartment of Endocrinology, Genetics, Metabolism
Sep 12, 2023
Obesity, Childhood, Cognition, Neurobehavioral Manifestations Trial in Auckland, Singapore, Southampton (Intervention (Study
Enrolling by invitation
- Obesity, Childhood
- +11 more
- Intervention (Study Nutritional Drink)
- Control (Standard Nutritional Drink)
-
Auckland, New Zealand
- +2 more
Jun 27, 2023
Grandparents, Growth Disorders, Development, Child Trial in Istanbul (Interaction-Based Early Education Program)
Not yet recruiting
- Grandparents
- +4 more
- Interaction-Based Early Education Program
-
Istanbul, TurkeyMarmara University
Jun 22, 2023
Growth Chart Parameters, Risk Factors
Not yet recruiting
- Growth Disorders
- good feeding, cleaning
- (no location specified)
Apr 22, 2023
Novel Growth Monitoring Smartphone App
Recruiting
- Short Stature
- Growth Disorders
-
London, United KingdomBarts Health NHS Trust
Apr 25, 2023
Long Read Genome Sequencing in Patients Suffering From
Recruiting
- Genetic Disease
- +3 more
-
Nantes, Loire-Atlantique, FranceNantes University Hospital
Jan 25, 2023
Growth Pattern and Characteristics of Cardiac Pediatric Patients
Not yet recruiting
- Growth Disorders
- (no location specified)
Oct 9, 2022
Child Growth and Development in East London
Recruiting
- Stunted Growth
- +3 more
-
London, United KingdomTower Hamlets GP Care Group
Sep 7, 2022
Growth Disorders Trial in Washington (Somatropin)
Enrolling by invitation
- Growth Disorders
-
Washington, District of ColumbiaChildren's National Hospital
Aug 29, 2022
Pediatric Growth Hormone Deficiency, Growth Disorders Trial in Sapporo (Somavaratan (VRS-317))
Terminated
- Pediatric Growth Hormone Deficiency
- Growth Disorders
- Somavaratan (VRS-317)
-
Sapporo, JapanHokkaido University Hospital
Jul 22, 2022
Health and Nutrition Survey on Shenzhen Children
Completed
- Nutrition Disorder, Child
- +10 more
-
Shenzhen, Guangdong, ChinaShenzhen Center for Chronic Disease Control
May 21, 2022
Evaluation of Digital Follow up of Preterm Infants
Recruiting
- Preterm Birth
- +4 more
- ePIPARI digital follow up tool
-
Turku, FinlandNICU/Pediatrics
Apr 11, 2022
Is ThereMicrobiome Associated With Poor Growth in Preterm
Recruiting
- Growth Disorders
- +2 more
- Caloric Requirement
-
Dallas, TexasParkland Hopsital and Health System
Mar 28, 2022
Growth Disorders, Malnutrition, Fetal, Stunting Trial in Quito (Evolutionary Nutrition Package)
Recruiting
- Growth Disorders
- +5 more
- Evolutionary Nutrition Package
-
Quito, Pichincha, EcuadorUniversidad San Francisco de Quito
Feb 6, 2022
Identifying New Genetic Causes to Development Disorders
Recruiting
- Disorders of Sex Development
- +2 more
- blood sample
-
Paris, FranceHôpital Fondation A de Rothschild
Jan 26, 2022
Growth Disorders Trial
Not yet recruiting
- Growth Disorders
- (no location specified)
Sep 15, 2021
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers
Not yet recruiting
- Hyperprolactinemia
- +4 more
-
Aalborg, Denmark
- +2 more
Sep 2, 2021
Proteus Syndrome, PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorders Trial (ARQ 092)
No longer available
- Proteus Syndrome
- +2 more
- ARQ 092
- (no location specified)
Jul 31, 2021
Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK
Completed
- Growth Disorders
- Easypod
-
Sutton, Surrey, United Kingdom
- +5 more
May 4, 2021
Early Childhood Cow's Milk Allergy Elimination Diet on Eating
Not yet recruiting
- Nutrient Deficiency
- +3 more
- Survey
-
Ankara, TurkeyGülhane Training and Research Hospital
Sep 30, 2020
Obesity, Child Development, Growth Disorders Trial in Leipzig
Recruiting
- Obesity
- +2 more
-
Leipzig, Saxony, GermanyCrescNet - University of Leipzig
Jul 24, 2020
Insulin-Like Growth Factor-1 Deficiency, Growth Disorders Trial in Brisbane (rhIGF-1 (mecasermin) for a period of 86 weeks)
Completed
- Insulin-Like Growth Factor-1 Deficiency
- Growth Disorders
- rhIGF-1 (mecasermin) for a period of 86 weeks
-
Brisbane, CaliforniaIpsen
Jul 7, 2020